Dutch chemicals company DSM NV will invest EUR 7 million in a new biopharmaceutical plant in Canada. The plant, to be located in Montreal , will have a capacity of 60,000 litres and will be used for the production of a new generation of drugs such as monoclonal antibodies and recombinant proteins.
For more projects, subscribe to our Project Preview Newsletter
